[1]
A. Khandelwal, M. Kawatra, V. Bhandari, and P. S. Yeshwante, “Imatinib resistance in chronic myelogenous leukemia: an emerging challenge”, Int J Basic Clin Pharmacol, vol. 3, no. 5, pp. 908–911, Jan. 2017.